| Reference | Published | View |
---|
Schmidt 2021 Cancer Metab | Schmidt CA, McLaughlin KL, Boykov IN, Mojalagbe R, Ranganathan A, Buddo KA, Lin CT, Fisher-Wellman KH, Neufer PD (2021) Aglycemic growth enhances carbohydrate metabolism and induces sensitivity to menadione in cultured tumor-derived cells. Cancer Metab 9:3. | 2021 | PMID: 33468237 Open Access |
Zunica 2021 Cancer Metab | Zunica ERM, Axelrod CL, Cho E, Spielmann G, Davuluri G, Alexopoulos SJ, Beretta M, Hoehn KL, Dantas WS, Stadler K, King WT, Pergola K, Irving BA, Langohr IM, Yang S, Hoppel CL, Gilmore LA, Kirwan JP (2021) Breast cancer growth and proliferation is suppressed by the mitochondrial targeted furazano[3,4-b]pyrazine BAM15. Cancer Metab 9:36. | 2021 | PMID: 34627389 Open Access |
Niu 2018 Cancer Metab | Niu X, Chen YJ, Crawford PA, Patti GJ (2018) Transport-exclusion pharmacology to localize lactate dehydrogenase activity within cells. Cancer Metab 6:19. | 2018 | PMID: 30559963 |
Schoeckel 2015 Cancer Metab | SchΓΆckel L, Glasauer A, Basit F, Bitschar K, Truong H, Erdmann G, Algire C, HΓ€gebarth A, Willems PH, Kopitz C, Koopman WJ, HΓ©roult M (2015) Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth. Cancer Metab 3:11. | 2015 | PMID: 26500770 Open Access |
Gaude 2014 Cancer Metab | Gaude E, Frezza C (2014) Defects in mitochondrial metabolism and cancer. Cancer Metab 2:10. | 2014 | PMID: 25057353 Open Access |
Verschoor 2013 Cancer Metab | Verschoor ML, Verschoor CP, Singh G (2013) Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancers. Cancer Metab 1:17. | 2013 | PMID: 24280356 Open Access |